New Products

United Biomedical Inc., based in Lake Success, N.Y., recently received approval from the U.S. Food and Drug Administration to market a new type of AIDS antibody screening and diagnostic test. The UBI-Olympus HIV-1 enzyme immunoassay (EIA) was jointly developed by United Biomedical Inc. and Olympus Inc. The UBI-Olympus test will be manufactured by UBI and marketed worldwide by Olympus Optical Co. Ltd. The new AIDS antibody test is based on I highly specific and conserved small peptide segments of

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Researchers in immunology, cell biology, and developmental biology frequently perform experiments designed to analyze the effect of various factors on target cells (for example, cellular chemotaxis). Such experiments require the use of culture chambers that are separated by a membrane to allow diffusion of macromolecules through both chambers while restricting the movement of Cells. NeuroProbe Inc., based in Cabin John, Md., has developed a variety of chemotaxis chambers designed to fulfill the requirements for experiments such as these. Ten-, 12-, and 48-well chemotaxis chambers, are available (priced at $250, $300, and $495, respectively). The chambers feature precision-machined, clear acrylic plates; polished well interiors (to facilitate cleaning and reduce the chance of contamination); raised rims around the mating surfaces of top and bottom wells (to facilitate sealing); and curved sealing surfaces (to distribute pressure evenly). The chambers are designed for use with either polycarbonate or cellulose nitrate separation filters. In addition, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies